RhoC-GTPase is a Novel Tissue Biomarker Associated with Biologically Aggressive Carcinomas of the Breast (original) (raw)

Summary

Background. There is a need for reliable predictors of breast cancer aggressiveness that will further refine the staging classification and help guide the implementation of novel therapies. We have identified RhoC as being nearly always overexpressed in the most aggressive form of breast cancer, inflammatory breast cancer (IBC); in subsequent work we identified RhoC to be a promising marker of aggressive behavior in breast cancers less than 1 cm in diameter. We hypothesized that RhoC expression would identify aggressive, non-IBC tumors breast cancer patients at any stage with worse outcomes defined as recurrence and/or metastasis.

Methods. We constructed four high-density tissue microarrays (TMAs) using 801 tissue cores from 280 patients. These tissues represent a wide range of normal breast and breast disease, including intraductal hyperplasia, ductal carcinoma in situ (DCIS), invasive carcinomas, and distant metastases. The TMAs were immunostained using a polyclonal anti-RhoC antibody developed in our laboratory. Cytoplasmic RhoC expression was scored as negative, weak, moderate, or strong by a previously validated scoring schema.

Results. RhoC expression increases with breast cancer progression. All samples of normal breast epithelium had negative to weak staining, whereas staining intensity increased in hyperplasia, DCIS, invasive carcinoma, and metastases (Kruskal–Wallis p < 0.001). In patients with invasive carcinoma, high RhoC expression was associated with features of aggressive behavior including high histologic grade, positive lymph nodes, and negative hormonal receptor status. High RhoC expression was a predictor of overall survival in patients with breast cancer (log rank test, p = 0.002) and was associated with 100% increase in the risk of death as compared to patients with low RhoC expression. Importantly, high RhoC was an independent predictor of poor response to doxorubicin-based chemotherapy with a hazard ratio of 3.1 and a 95% CI of 1.2–7.7 (p = 0.02).

Conclusion. RhoC expression increases with breast cancer progression and RhoC protein level in tumor tissue is strongly associated with biologically aggressive invasive carcinomas of the breast. RhoC expression, if validated, may identify patients who are less likely benefit from doxorubicin therapy and suggests RhoC overexpression as a new target for intervention.

Access this article

Log in via an institution

Subscribe and save

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

References

  1. A Jemal T Murray A Samuels A Ghafoor E Ward MJ Thun (2003)ArticleTitleCancer statistics CA_Cancer J Clin_ 53 5–26Occurrence Handle12568441
    PubMed Google Scholar
  2. M Ellis D Hayes M Lippman (2000) Treatment of metastatic disease J Harris ME Lippman M Morrow (Eds) Diseases of the Breast Lippincott-Raven Philadelpha 749–798
    Google Scholar
  3. DF Hayes C Isaacs V Stearns (2001)ArticleTitlePrognostic factors in breast cancer: current and new predictors of metastasis_J Mammary Gland Biol Neoplasia_ 6 375–392Occurrence Handle10.1023/A:1014778713034Occurrence Handle12013528
    Article PubMed Google Scholar
  4. DF Hayes B Trock AL Harris (1998)ArticleTitleAssessing the clinical impact of prognostic factors: when is “statistically significant” clinically useful?Breast Cancer Res Treat 52 305–319Occurrence Handle10.1023/A:1006197805041Occurrence Handle10066089
    Article PubMed Google Scholar
  5. GM Clark (1996) Prognostic and predictive factors LM. J Harris M Morrow S Hellman (Eds) , Diseases of the Breast Lipponcott-Raven Publishers Philadephia 461–485
    Google Scholar
  6. Hayes (2000)ArticleTitleDo we need prognostic factors in nodal-negative breast cancer?Arbiter Eur J Cancer 36 302–306Occurrence Handle10.1016/S0959-8049(99)00303-2
    Article Google Scholar
  7. KL GolenParticlevan S Davies ZF Wu Y Wang CD Bucana H Root S Chandrasekharappa M Strawderman SP Ethier SD Merajver (1999)ArticleTitleA novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype_Clin Cancer Res_ 5 2511–2519Occurrence Handle10499627
    PubMed Google Scholar
  8. KL GolenParticlevan ZF Wu XT Qiao L Bao SD Merajver (2000)ArticleTitleRhoC GTPase overexpression modulates induction of angiogenic factors in breast cells_Neoplasia_ 2 418–425Occurrence Handle10.1038/sj.neo.7900115Occurrence Handle11191108
    Article PubMed Google Scholar
  9. KL GolenParticlevan ZF Wu XT Qiao LW Bao SD Merajver (2000)ArticleTitleRhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype_Cancer Res_ 60 5832–5838Occurrence Handle11059780
    PubMed Google Scholar
  10. CG Kleer KL GolenParticlevan Y Zhang ZF Wu MA Rubin SD Merajver (2002)ArticleTitleCharacterization of RhoC expression in benign and malignant breast disease : a potential new marker for small breast carcinomas with metastatic ability_Am J Pathol_ 160 579–584Occurrence Handle11839578
    PubMed Google Scholar
  11. CG Kleer Q Cao S Varambally R Shen I Ota SA Tomlins D Ghosh RG Sewalt AP Otte DF Hayes MS Sabel D Livant SJ Weiss MA Rubin AM Chinnaiyan (2003)ArticleTitleEZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells_Proc Natl Acad Sci USA_ 100 11606–11611Occurrence Handle10.1073/pnas.1933744100Occurrence Handle14500907
    Article PubMed Google Scholar
  12. EE Perrone C Theoharis NR Mucci S Hayasaka JM Taylor KA Cooney MA Rubin (2000)ArticleTitleTissue microarray assessment of prostate cancer tumor proliferation in African-American and white men_J Natl Cancer Inst_ 92 937–939Occurrence Handle10.1093/jnci/92.11.937Occurrence Handle10841830
    Article PubMed Google Scholar
  13. EW Elston IO Ellis (1993)ArticleTitleMethod for grading breast cancer_J Clin Pathol_ 46 189–190
    Google Scholar
  14. S Manley NR Mucci AM MarzoParticleDe MA Rubin (2001)ArticleTitleRelational database structure to manage high-density tissue microarray data and images for pathology studies focusing on clinical outcome: the prostate specialized program of research excellence model_Am J Pathol_ 159 837–843Occurrence Handle11549576
    PubMed Google Scholar
  15. DR Rhodes MG Sanda AP Otte AM Chinnaiyan MA Rubin (2003)ArticleTitleMultiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer_J Natl Cancer Inst_ 95 661–668Occurrence Handle12734317
    PubMed Google Scholar
  16. CD Nobes A Hall (1995)ArticleTitleRho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia_Cell_ 81 53–62Occurrence Handle10.1016/0092-8674(95)90370-4Occurrence Handle7536630
    Article PubMed Google Scholar
  17. A Hall CD Nobes (2000)ArticleTitleRho GT Pases molecular switches that control the organization and dynamics of the actin cytoskeleton_Philos Trans R Soc Lond B Biol Sci_ 355 965–970Occurrence Handle10.1098/rstb.2000.0632Occurrence Handle11128990
    Article PubMed Google Scholar
  18. T Leung XQ Chen E Manser L Lim (1996)ArticleTitleThe p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton_Mol Cell Biol_ 16 5313–5327Occurrence Handle8816443
    PubMed Google Scholar
  19. CG Kleer Y Zhang Q Pan G Gallagher M Wu ZF Wu SD Merajver (2004)ArticleTitleWISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer_Breast Cancer Res_ 6 R110–R115Occurrence Handle10.1186/bcr755
    Article Google Scholar
  20. MA Wozniak R Desai PA Solski CJ Der PJ Keely (2003)ArticleTitleROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix_J Cell Biol_ 163 583–595Occurrence Handle10.1083/jcb.200305010Occurrence Handle14610060
    Article PubMed Google Scholar
  21. H Suwa G Ohshio T Imamura G Watanabe S Arii M Imamura S Narumiya H Hiai M Fukumoto (1998)ArticleTitleOverexpression of the RhoC gene correlates with progression of ductal adenocarcinoma of the pancreas_Br J Cancer_ 77 147–152Occurrence Handle9459160
    PubMed Google Scholar
  22. A Horiuchi T Imai C Wang S Ohira Y Feng T Nikaido I Konishi (2003)ArticleTitleUp-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma_Lab Invest_ 83 861–870Occurrence Handle12808121
    PubMed Google Scholar
  23. T Kamai T Tsujii K Arai K Takagi H Asami Y Ito H Oshima (2003)ArticleTitleSignificant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer_Clin Cancer Res_ 9 2632–2641Occurrence Handle12855641
    PubMed Google Scholar
  24. T Kondo K Sentani N Oue K Yoshida H Nakayama W Yasui (2004)ArticleTitleExpression of RHOC is associated with metastasis of gastric carcinomas_Pathobiology_ 71 19–25Occurrence Handle10.1159/000072958Occurrence Handle14555841
    Article PubMed Google Scholar
  25. Y Shikada I Yoshino T Okamoto S Fukuyama T Kameyama Y Maehara (2003)ArticleTitleHigher expression of RhoC is related to invasiveness in non-small cell lung carcinoma_Clin Cancer Res_ 9 5282–5286Occurrence Handle14614010
    PubMed Google Scholar
  26. W Wang LY Yang ZL Yang GW Huang WQ Lu (2003)ArticleTitleExpression and significance of RhoC gene in hepatocellular carcinoma_World J Gastroenterol_ 9 1950–1953Occurrence Handle12970882
    PubMed Google Scholar
  27. T Ikoma T Takahashi S Nagano YM Li Y Ohno K Ando T Fujiwara H Fujiwara K Kosai (2004)ArticleTitleA definitive role of RhoC in metastasis of orthotopic lung cancer in mice_Clin Cancer Res_ 10 1192–1200Occurrence Handle14871999
    PubMed Google Scholar
  28. EA Clark TR Golub ES Lander RO Hynes (2000)ArticleTitleGenomic analysis of metastasis reveals an essential role for RhoC_Nature_ 406 532–535Occurrence Handle10.1038/35020106Occurrence Handle10952316
    Article PubMed Google Scholar
  29. KM Carr M Bittner JM Trent (2003)ArticleTitleGene-expression profiling in human cutaneous melanoma_Oncogene_ 22 3076–3080Occurrence Handle10.1038/sj.onc.1206448Occurrence Handle12789283
    Article PubMed Google Scholar
  30. MC Seabra (1998)ArticleTitleMembrane association and targeting of prenylated Ras-like GTPases_Cell Signal_ 10 167–172Occurrence Handle10.1016/S0898-6568(97)00120-4Occurrence Handle9607139
    Article PubMed Google Scholar
  31. PT Kirschmeier D Whyte O Wilson WR Bishop JK Pai (2001)ArticleTitle_In vivo_ prenylation analysis of Ras and Rho proteins_Methods Enzymol_ 332 115–127Occurrence Handle11305090
    PubMed Google Scholar
  32. P Adamson CJ Marshall A Hall PA Tilbrook (1992)ArticleTitlePost-translational modifications of p21rho proteins_J Biol Chem_ 267 20033–20038Occurrence Handle1400319
    PubMed Google Scholar
  33. M Sinensky (2000)ArticleTitleRecent advances in the study of prenylated proteins_Biochim Biophys Acta_ 1484 93–106Occurrence Handle10760460
    PubMed Google Scholar
  34. AL Bishop A Hall (2000)ArticleTitleRho GTPases and their effector proteins_Biochem J_ 348 IssueIDPt2 241–255Occurrence Handle10.1042/0264-6021:3480241Occurrence Handle10816416
    Article PubMed Google Scholar
  35. CA Omer Z Chen RE Diehl MW Conner HY Chen ME Trumbauer S Gopal-Truter G Seeburger H Bhimnathwala MT Abrams JP Davide MS Ellis JB Gibbs I Greenberg KS Koblan AM Kral D Liu RB Lobell PJ Miller SD Mosser TJ O’Neill E Rands MD Schaber ET Senderak A Oliff NE Kohl (2000)ArticleTitleMouse mammary tumor virus-Ki-rasB transgenic mice develop mammary carcinomas that can be growth-inhibited by a farnesyl:protein transferase inhibitor_Cancer Res_ 60 2680–2688Occurrence Handle10825141
    PubMed Google Scholar
  36. GC Prendergast R Khosravi-Far PA Solski H Kurzawa PF Lebowitz CJParticleDer (1995)ArticleTitleCritical role of Rho in cell transformation by oncogenic Ras_Oncogene_ 10 2289–2296Occurrence Handle7784077
    PubMed Google Scholar
  37. GC Prendergast JP Davide SJ deSolms EA Giuliani SL Graham JB Gibbs A Oliff NE Kohl (1994)ArticleTitleFarnesyltransferase inhibition causes morphological reversion of ras-transformed cells by a complex mechanism that involves regulation of the actin cytoskeleton_Mol Cell Biol_ 14 4193–4202Occurrence Handle8196657
    PubMed Google Scholar
  38. PF Lebowitz PJ Casey GC Prendergast JA Thissen (1997)ArticleTitleFarnesyltransferase inhibitors alter the prenylation and growth-stimulating function of RhoB_J Biol Chem_ 272 15591–15594Occurrence Handle10.1074/jbc.272.25.15591Occurrence Handle9188444
    Article PubMed Google Scholar
  39. KL GolenParticlevan L Bao MM DiVito Z Wu GC Prendergast SD Merajver (2002)ArticleTitleReversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor_Mol Cancer Ther_ 1 575–583Occurrence Handle12479217
    PubMed Google Scholar
  40. EA Collisson C Kleer M Wu A De SS Gambhir SD Merajver MS Kolodney (2003)ArticleTitleAtorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells_Mol Cancer Ther_ 2 941–948Occurrence Handle14578459
    PubMed Google Scholar

Download references

Author information

Authors and Affiliations

  1. Department of Pathology and Internal Medicine, University of Michigan, Ann Arbour, MI, USA
    Celina G. Kleer & Gary Gallagher
  2. Department of Biostatistics and Internal Medicine, University of Michigan, Ann Arbour, MI, USA
    Kent A. Griffith
  3. Department of Surgery and Internal Medicine, University of Michigan, Ann Arbour, MI, USA
    Michael S. Sabel
  4. Division of Hematology/Oncology, University of Michigan, Ann Arbour, MI, USA
    Kenneth L. van Golen, Zhi-Fen Wu & Sofia D. Merajver
  5. Comprehensive Cancer Center, University of Michigan, Ann Arbour, MI, USA
    Celina G. Kleer, Kent A. Griffith, Michael S. Sabel, Kenneth L. van Golen, Zhi-Fen Wu & Sofia D. Merajver

Authors

  1. Celina G. Kleer
  2. Kent A. Griffith
  3. Michael S. Sabel
  4. Gary Gallagher
  5. Kenneth L. van Golen
  6. Zhi-Fen Wu
  7. Sofia D. Merajver

Corresponding author

Correspondence toCelina G. Kleer.

Rights and permissions

About this article

Cite this article

Kleer, C.G., Griffith, K.A., Sabel, M.S. et al. RhoC-GTPase is a Novel Tissue Biomarker Associated with Biologically Aggressive Carcinomas of the Breast.Breast Cancer Res Treat 93, 101–110 (2005). https://doi.org/10.1007/s10549-005-4170-6

Download citation

Keywords